Malignant neoplasm of occipital lobe
ICD-10 C71.4 is a billable code used to indicate a diagnosis of malignant neoplasm of occipital lobe.
C71.4 refers to a malignant neoplasm located in the occipital lobe of the brain, which is responsible for visual processing. These tumors can arise from glial cells (gliomas), meningeal tissue (meningiomas), or metastasize from other primary cancers. Symptoms may include visual disturbances, headaches, seizures, and cognitive changes, depending on the tumor's size and location. Imaging studies such as MRI or CT scans are crucial for diagnosis, revealing the tumor's size, location, and potential involvement of surrounding structures. Molecular markers, including IDH1/2 mutations and 1p/19q co-deletion status, can provide insights into tumor behavior and guide treatment decisions. Neurological function may be significantly impacted, necessitating a multidisciplinary approach for management, including neurosurgery, radiation therapy, and chemotherapy. Accurate coding is essential for appropriate treatment planning and reimbursement.
Detailed neurological examination findings, imaging results, and treatment plans.
Patients presenting with visual disturbances, seizures, or cognitive changes.
Ensure comprehensive documentation of neurological assessments and imaging interpretations.
Histopathological reports, molecular marker testing results, and treatment response evaluations.
Management of patients undergoing chemotherapy or radiation therapy for brain tumors.
Document all treatment modalities and their effects on tumor progression.
Used when a patient undergoes surgical resection of an occipital lobe tumor.
Operative report detailing the procedure and findings.
Neurosurgical documentation must include pre-operative imaging and post-operative assessments.
Used for imaging to assess the tumor's characteristics.
Radiology report with imaging findings and interpretations.
Ensure clarity on the imaging technique and findings related to the occipital lobe.
MRI or CT scans are essential for diagnosing and documenting the presence of a malignant neoplasm in the occipital lobe. Ensure that the imaging reports are included in the patient's medical record.
Molecular markers can provide additional information regarding the tumor's behavior and treatment response, which should be documented to support the coding of C71.4.
